Clinical trials

9

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Use of Propofol as a Sedative Agent Versus Spinal Analgesia With Bupivacaine in External Cephalic Version

External Cephalic Version (ECV) is a maneuver to modify fetal position in pregnant women with a non-cephalic presentation. Its objective is to achieve a cephalic presentation that allows for vaginal delivery with less risk than a vaginal breech delivery or a cesarean section. ECV is an effective technique to reduce the rate of cesarean sections and is recommended by the Spanish Society of Obstetrics and Gynecology (SEGO) and the World Health Organization (WHO) Cesarean Section Working Group. The WHO aims to reduce interventionism in childbirth globally and implement non-clinical measures to reduce the rate of unnecessary cesarean sections. Despite Propofol is a sedative agent commonly used by anesthesiologist in countless ambulatory procedures in obstetric anaesthesia, it has been little studied in ECV, and its effect has not been compared with other commonly used agents such as remifentanil or spinal analgesia. The Obstetric Anesthesiology Section of the Spanish Society of Anesthesiology and Resuscitation recommends the use of locoregional analgesia in ECV.

Participants needed: 270
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: Fundacion para la Formacion e Investigacion Sanitarias de la Region de MurciaUpdated: Nov 21, 2025Locations: 1
Eligibility criteria

Voluntary participation. [+4]

Age under 18 years old. [+13]

Status: Not yet recruiting

Standardized Resistance Training Program and Assessment System for Prostate Cancer Patients Receiving Androgen Deprivation Therapy ISPoRT-PCa-ADT Study Protocol for a Randomized Controlled Trial. SPORT-MU

This randomized controlled trial (RCT) with two parallel study arms evaluated the effectiveness of a 24-week exercise intervention in prostate cancer (PCa) patients under-going androgen deprivation therapy (ADT). Ethical approval was obtained from the Clinical Research Ethics Committee of the University Clinical Hospital "Virgen de la Arrixaca" (Murcia, Spain). Participants were randomly assigned to one of two groups: (1) a supervised progressive resistance training program (SPoRT-PCa-ADT), or (2) a control group receiving a home-based exercise protocol following an initial assessment, accom-panied by weekly telephone follow-up. Assessments were conducted at baseline and at 24 weeks to examine changes in physical, functional, and psychosocial outcomes. Addi-tionally, patient-reported outcomes were collected at the 12-week midpoint (Figure 1). This study design enabled the evaluation of both immediate and sustained intervention effects and facilitated a direct comparison between supervised and home-based exercise approaches

Participants needed: 60
Trial details
Age: 18+Biological sex: MaleType: InterventionalSponsor: Fundacion para la Formacion e Investigacion Sanitarias de la Region de MurciaUpdated: Jul 15, 2025Locations: 1
Eligibility criteria

diagnosis of locally advanced or metastatic prostate neoplasm and current treatm... [+2]

unwillingness to participate in the study [+3]

Status: Recruiting

Combined Intraperitoneal Chemotherapy Regimen After Optimal Interval Surgery in Advanced Ovarian Cancer: BICOV-1 (Bidirectional Chemotherapy in Ovarian Cancer)

A multicenter, low-intervention, drug-based study to evaluate the feasibility and safety of a combined regimen of two intraperitoneal chemotherapy modalities (used in routine clinical practice) following interval surgery for the treatment of advanced ovarian cancer. This is an independent research project (free of commercial interests).

Participants needed: 20
Trial details
Age: 18-70Biological sex: FemaleType: InterventionalSponsor: Fundacion para la Formacion e Investigacion Sanitarias de la Region de MurciaUpdated: Mar 30, 2025Locations: 1
Eligibility criteria

Women aged 18-70 years with a histologically proven diagnosis of FIGO stage IIIB... [+10]

Disease progression during systemic treatment with neoadjuvant chemotherapy. [+8]

Status: Recruiting

Creation of a National Multicenter Platform for the Study of Inflammatory Myocardial Disease: Pre-MYO Cohort

The objectives of this project are: 1) to comprehensively characterize a large national cohort of patients with suspected myocarditis, their clinical phenotype, care management, blood and imaging biomarkers, epidemiological, environmental and genetic data; 2) to retrospectively validate the accuracy of the new hsa-RNA-Chr8:96 biomarker for the diagnosis of myocarditis compared to conventional diagnosis; 3) to identify acquired and inherited mutations, and their interaction with the environment, which explain the susceptibility to myocarditis, its severity and response to treatment; 4) to study the lower incidence in women and the influence of age, considering socio-health and genetic factors.

Participants needed: 3,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Fundacion para la Formacion e Investigacion Sanitarias de la Region de MurciaUpdated: Mar 27, 2025Locations: 1Duration: 3 Years
Eligibility criteria

Acute chest pain: pericardial or pseudo-ischemic. [+8]

Status: Recruiting

First Trimester Prediction of Gestational Diabetes Mellitus by Continuous Glucose Monitoring.

Gestational diabetes mellitus (GDM) is the most common complication of pregnancy, with an incidence rate of 10-15% \[1\]. Common risk factors for GDM are increased maternal age and weight and as a consequence of women delaying childbirth and increasing incidence of obesity, there is a corresponding increase in the rate of GDM. GDM is associated with an increased risk of maternal and perinatal short and long-term complications . These include macrosomia, shoulder dystocia, neonatal hypoglycaemia, neonatal hyperbilirubinemia, and perinatal mortality. Maternal complications include higher risks of hypertensive disorders, perineal trauma, and caesarean section. Additionally, both the mothers with GDM and their infants have an increased risk of developing type 2 diabetes mellitus and cardiovascular disease later in life . Screening and diagnosis of GDM is currently based on an oral glucose tolerance (OGTT), which is carried out at 26-28 weeks' gestation. In addition, an OGTT is carried out at 11-13 weeks in women considered to be at increased risk of GDM based on their demographic characteristics and medical history. Screening and diagnosis of GDM is traditionally delayed until the late second or early third trimester of pregnancy with the rationale that the diabetogenic effects of pregnancy increase with gestation and therefore delayed testing would maximize the detection rate.

Participants needed: 1,000
Trial details
Age: 18+Biological sex: FemaleType: ObservationalSponsor: Fundacion para la Formacion e Investigacion Sanitarias de la Region de MurciaUpdated: Mar 13, 2025Locations: 1Duration: 2 Years
Eligibility criteria

Maternal age ≥ 18 years [+3]

Age <18 years; [+11]

Status: Recruiting

Long Acting Cabotegravir Plus Rilpivirine in People Living with HIV-1 Aged ≥ 60 Years for 24 Months.

People Living with HIV-1 (PLHIV) are an important group of patients attending their specialist's and continue growing thanks to efficacy antiretroviral treatment (ART), allowing them to stabilize the HIV-infection and to live a normal life despite the infection. The present study is encouraged to demonstrate that efficacy and security of CAB LA + RPV LA treatment's on this population remains the same compared to younger population of patients. This study also registers some metabolic and hepatic parameters to observe a hypothetical improvement on these parameters, as the population may suffer more comorbidities than younger population and therefore tolerability and convenience gains a huge importance on them. Psychosocial aspects are also very important in these patients as these patients may suffer social stigma, and therefore suffering certain psychological disorders.

Participants needed: 120
Trial details
Phase: Phase 4Age: 60+Biological sex: AllType: InterventionalSponsor: Fundacion para la Formacion e Investigacion Sanitarias de la Region de MurciaUpdated: Mar 11, 2025Locations: 8
Eligibility criteria

Be able to understand and comply with protocol requirements, instructions, and r... [+5]

Plasma HIV-1 RNA measurement ≥50 copies/mL within 6 months prior to screening. B... [+4]

Status: Recruiting

Study of Maternal and Fetal Cardiovascular Function in Hypertensive States of Pregnancy

The pharmacological treatment strategy is then tailored to the underlying hemodynamic phenotype of each patient. That is, rather than applying a one-size-fits-all treatment for all patients, therapy is tailored to the specific characteristics of how the cardiovascular system functions in each patient (e.g., whether the problem is more related to blood volume, vascular resistance, cardiac output, etc.). The goal is to personalize therapy to more effectively treat hypertensive states of pregnancy.

Participants needed: 50
Trial details
Age: 18+Biological sex: FemaleType: ObservationalSponsor: Fundacion para la Formacion e Investigacion Sanitarias de la Region de MurciaUpdated: Mar 5, 2025Locations: 1Duration: 1 Year
Eligibility criteria

Age greater than or equal to 18 years [+1]

Minors under 18 years of age. [+2]

Status: Recruiting

Multicenter Study on the Correction of Prolapse Via Laparoscopy

In the laparoscopic lateral suspension (LLS) technique, the fixation of the mesh as a prosthetic element for correcting anterior apical vaginal prolapse at the level of the dome or uterus can offer anatomical and functional results that are not inferior to those of the conventional surgical technique, minimize possible intraoperative complications and facilitate the specific learning curve of sacropexy.

Participants needed: 181
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: Fundacion para la Formacion e Investigacion Sanitarias de la Region de MurciaUpdated: Feb 7, 2025Locations: 1
Eligibility criteria

Patients with Stage II- IV primary or recurrent prolapse affecting the anterior...

History of abdominal prolapse reconstructive surgery. [+5]

Status: Not yet recruiting

Efficacy of Self-titration of Ventilation in Overlap Syndrome (chronic Obstructive Pulmonar Disease + Sleep Apnea Syndrome ) with Dynamic Hyperinflation. EDIN-IDIN.

The combination of COPD and obstructive sleep apnea (OSA) can lead to undesirable interactions with the treatment approach. The investigators know that continuous positive airway pressure (CPAP) can increase dynamic hyperinflation in COPD patients, and in mechanical ventilation, the increase in PEEP can worsen dynamic hyperinflation. On the other hand, the team know that the severity of COPD obstruction and hyperinflation alter sleep efficiency, with periods of wakefulness during sleep, and during these periods, the patient would not have upper airway obstruction, which could affect the therapy they are receiving in CPAP mode for OSA. Moreover, it was observed that with greater hyperinflation, the rate of obstructive events decreases, dynamically affecting the ventilatory situation with upper airway resistance. Recent studies have determined the safety and efficacy of auto-adjusting systems in the treatment of overlap syndrome, which could be more adaptable to the changing pulmonary mechanics of these patients. Aerobic capacity is a good predictor to the health status in these patients and the investigators know it is reduced in patients with AOS, where CPAP treatment according to studies improves the peak VO2. Therefore, the objective is to compare a ventilation system with fixed pressures established through polysomnography in patients with overlap syndrome and dynamic hyperinflation to a dynamic ventilation system using the fixed pressure limits typically established, based on their impact on the aerobic capacity (peak VO2) of these patients after 1 month of treatment.

Participants needed: 20
Trial details
Age: 50-80Biological sex: AllType: InterventionalSponsor: Fundacion para la Formacion e Investigacion Sanitarias de la Region de MurciaUpdated: Dec 3, 2024Locations: 1
Eligibility criteria

Stability of at least 4 weeks without hospital admission. [+4]

Refusal to participate in the study. [+11]